Plethico Pharmaceuticals Ltd: Outcome of Board Meeting

Plethico Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 13, 2011, inter alia, considered the options of managing the liabilities of the Company through various initiatives such as amending the terms and conditions of the outstanding Foreign Currency Convertible Bonds issued on October 2007 ("FCCBs"), including but not limited to tenor, interest rate, yield to maturity, other methods of extinguishing FCCBs, including and not limited to repurchase, redemption, buyback, either wholly, partly or in tranches etc., or restructuring of FCCBs in compliance with applicable regulations.